164 related articles for article (PubMed ID: 38186686)
21. SPAG5 promotes the proliferation, migration, invasion, and epithelial-mesenchymal transformation of colorectal cancer cells by activating the PI3K/AKT signaling pathway.
Zhang X; Wu W; Li X; He F; Zhang L
Chin J Physiol; 2023; 66(5):365-371. PubMed ID: 37929348
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of colorectal cancer tumorigenesis by ursolic acid and doxorubicin is mediated by targeting the Akt signaling pathway and activating the Hippo signaling pathway.
Hu D; Meng RY; Nguyen TV; Chai OH; Park BH; Lee JS; Kim SM
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36382656
[TBL] [Abstract][Full Text] [Related]
23. [Decursin affects proliferation, apoptosis, and migration of colorectal cancer cells through PI3K/Akt signaling pathway].
Yang Y; Hu YE; Zhao MY; Jiang YF; Fu X; You FM
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2334-2342. PubMed ID: 37282862
[TBL] [Abstract][Full Text] [Related]
24. Actein antagonizes colorectal cancer through blocking PI3K/Akt pathways by downregulating IMPDH2.
Yan L; Wang D; Liu X; Gu C; Gao S
Anticancer Drugs; 2021 Sep; 32(8):864-874. PubMed ID: 33929996
[TBL] [Abstract][Full Text] [Related]
25. DEPDC1B is involved in the proliferation, metastasis, cell cycle arrest and apoptosis of colon cancer cells by regulating NUP37.
Xiong H; Li Y; Liu M
Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37203403
[TBL] [Abstract][Full Text] [Related]
26. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
27. To Investigate the Occurrence and Development of Colorectal Cancer Based on the PI3K/AKT/mTOR Signaling Pathway.
Zhong J; Ding S; Zhang X; Di W; Wang X; Zhang H; Chen Y; Zhang Y; Hu Y
Front Biosci (Landmark Ed); 2023 Feb; 28(2):37. PubMed ID: 36866550
[TBL] [Abstract][Full Text] [Related]
28. Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway.
Soo HC; Chung FF; Lim KH; Yap VA; Bradshaw TD; Hii LW; Tan SH; See SJ; Tan YF; Leong CO; Mai CW
PLoS One; 2017; 12(1):e0170551. PubMed ID: 28107519
[TBL] [Abstract][Full Text] [Related]
29. Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
Lee MH; Hong SH; Park C; Kim GY; Leem SH; Choi SH; Keum YS; Hyun JW; Kwon TK; Hong SH; Choi YH
Oncol Rep; 2016 Jul; 36(1):205-14. PubMed ID: 27221553
[TBL] [Abstract][Full Text] [Related]
30. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
[TBL] [Abstract][Full Text] [Related]
32. Hesperetin Inhibits Bladder Cancer Cell Proliferation and Promotes Apoptosis and Cycle Arrest by PI3K/AKT/FoxO3a and ER Stress-mitochondria Pathways.
Su Y; Chen L; Yang J
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38357946
[TBL] [Abstract][Full Text] [Related]
33. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
[TBL] [Abstract][Full Text] [Related]
34. ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma.
Ran L; Mou X; Peng Z; Li X; Li M; Xu D; Yang Z; Sun X; Yin T
Sci Rep; 2023 Nov; 13(1):19477. PubMed ID: 37945707
[TBL] [Abstract][Full Text] [Related]
35. KCNE4 expression is correlated with the pathological characteristics of colorectal cancer patients and associated with the radioresistance of cancer cells.
Tian K; Tao Z; Chen Y; Du J; Chen M; Wang D; Li Z
Pathol Res Pract; 2023 Jan; 241():154234. PubMed ID: 36459833
[TBL] [Abstract][Full Text] [Related]
36. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
37. Breviscapine regulates the proliferation, migration, invasion, and apoptosis of colorectal cancer cells via the PI3K/AKT pathway.
Niu P; Liu F; Lei F; Peng J; Wang Y; Zhao J; Gao Z; Gao Q; Gu J
Sci Rep; 2023 Jun; 13(1):9674. PubMed ID: 37316553
[TBL] [Abstract][Full Text] [Related]
38. AMP-kinase inhibitor dorsomorphin reduces the proliferation and migration behavior of colorectal cancer cells by targeting the AKT/mTOR pathway.
Ghanaatgar-Kasbi S; Amerizadeh F; Rahmani F; Hassanian SM; Khazaei M; Ferns GA; Avan A
IUBMB Life; 2019 Dec; 71(12):1929-1936. PubMed ID: 31359579
[TBL] [Abstract][Full Text] [Related]
39. Network pharmacology and in vitro experiments reveal sophoridine-induced apoptosis and G
Su Y; Chen L; Yang J
Chem Biol Drug Des; 2024 Feb; 103(2):e14476. PubMed ID: 38346772
[TBL] [Abstract][Full Text] [Related]
40. The PI3K/Akt pathway is involved in procyanidin-mediated suppression of human colorectal cancer cell growth.
Choy YY; Fraga M; Mackenzie GG; Waterhouse AL; Cremonini E; Oteiza PI
Mol Carcinog; 2016 Dec; 55(12):2196-2209. PubMed ID: 26774105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]